Tissue plasminogen activator does not alter development of acquired epilepsy

Epilepsia

Volumn 53, Issue 11, 2012, Pages 1998-2004

  Tan, Mei Lyn ^a   Ng, Ashley ^a   Pandher, Puneet S ^a   Sashindranath, Maithili ^b   Hamilton, John A ^a   Davis, Stephen M ^a,c   O'Brien, Terence J ^a   Medcalf, Robert L ^b   Yan, Bernard ^a,c   Jones, Nigel C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Electrical kindling; Epilepsy; Ischemic stroke; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CONTROLLED STUDY; EPILEPSY; EPILEPTOGENESIS; FEMALE; HUMAN; KINDLING; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE THRESHOLD;

AGED; AGED, 80 AND OVER; ANIMALS; BRAIN ISCHEMIA; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KINDLING, NEUROLOGIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MIDDLE AGED; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84869095032     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03635.x     Document Type: Article

References (38)

1. Adeoye O, Hornung R, Khatri P, Kleindorfer D,. (2011) Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 42: 1952-1955.
2. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C,. (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337: 1521-1526.
3. Baranes D, Lederfein D, Huang YY, Chen M, Bailey CH, Kandel ER,. (1998) Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21: 813-825. (Pubitemid 28498789)
4. Barnes P, Thomas KL,. (2008) Proteolysis of proBDNF is a key regulator in the formation of memory. PLoS ONE 3: e3248.
5. Binder DK, Croll SD, Gall CM, Scharfman HE,. (2001) BDNF and epilepsy: too much of a good thing? Trends Neurosci 24: 47-53. (Pubitemid 32332896)
6. Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Cote R, Lebrun L, Pirisi A, Norris JW,. (2000) Seizures after stroke: a prospective multicenter study. Arch Neurol 57: 1617-1622.
7. Bland JM, Altman DG,. (1998) Survival probabilities (the Kaplan-Meier method). BMJ 317: 1572. (Pubitemid 128719735)
8. Cesarman-Maus G, Hajjar KA,. (2005) Molecular mechanisms of fibrinolysis. Br J Haematol 129: 307-321. (Pubitemid 40646889)
9. Cheung CM, Tsoi TH, Au-Yeung M, Tang AS,. (2003) Epileptic seizure after stroke in Chinese patients. J Neurol 250: 839-843. (Pubitemid 36898117)
10. De Reuck J, Van Maele G,. (2010) Acute ischemic stroke treatment and the occurrence of seizures. Clin Neurol Neurosurg 112: 328-331.
11. Ernfors P, Bengzon J, Kokaia Z, Persson H, Lindvall O,. (1991) Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 7: 165-176.
12. Gingrich MB, Traynelis SF,. (2000) Serine proteases and brain damage-is there a link? Trends Neurosci 23: 399-407.
13. Goldberger G, Colten HR,. (1980) Precursor complement protein (pro-C4) is converted in vitro to native C4 by plasmin. Nature 286: 514-516.
14. He XP, Kotloski R, Nef S, Luikart BW, Parada LF, McNamara JO,. (2004) Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model. Neuron 43: 31-42. (Pubitemid 38952817)
15. Horwood JM, Ripley TL, Stephens DN,. (2001) DRL performance in mice with deletion of tPA, uPA or PAI-1 genes. Behav Pharmacol 12: 487-496. (Pubitemid 33152273)
16. Jefferys JG,. (2010) Advances in understanding basic mechanisms of epilepsy and seizures. Seizure 19: 638-646.
17. Madani R, Hulo S, Toni N, Madani H, Steimer T, Muller D, Vassalli JD,. (1999) Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. EMBO J 18: 3007-3012. (Pubitemid 29255609)
18. Medcalf RL,. (2011) Plasminogen activation-based bhrombolysis for ischaemic stroke: the diversity of targets may demand new approaches. Curr Drug Targets 12: 1772-1781.
19. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A,. (2001) The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7: 59-64.
20. Niego B, Horvath A, Coughlin PB, Pugsley MK, Medcalf RL,. (2008) Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid. Blood Coagul Fibrinolysis 19: 322-324. (Pubitemid 351670419)
21. Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, Teng KK, Yung WH, Hempstead BL, Lu B,. (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306: 487-491. (Pubitemid 39372449)
22. Pawlak R, Magarinos AM, Melchor J, McEwen B, Strickland S,. (2003) Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nat Neurosci 6: 168-174. (Pubitemid 36182786)
23. Paxinos G, Franklin KBJ,. (2008) The mouse brain in stereotaxic coordinates, 3rd Edn, Elsevier Academic Press, New York.
24. Qian Z, Gilbert ME, Colicos MA, Kandel ER, Kuhl D,. (1993) Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361: 453-457. (Pubitemid 23050134)
25. Racine RJ,. (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281-294.
26. Ryvlin P, Montavont A, Nighoghossian N,. (2006) Optimizing therapy of seizures in stroke patients. Neurology 67: S3-S9. (Pubitemid 44967989)
27. Salzberg M, Kumar G, Supit L, Jones NC, Morris MJ, Rees S, O'Brien TJ,. (2007) Early postnatal stress confers enduring vulnerability to limbic epileptogenesis. Epilepsia 48: 2079-2085. (Pubitemid 350098766)
28. Samson AL, Nevin ST, Croucher D, Niego B, Daniel PB, Weiss TW, Moreno E, Monard D, Lawrence DA, Medcalf RL,. (2008) Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function. J Neurochem 107: 1091-1101.
29. Sashindranath M, Samson AL, Downes CE, Crack PJ, Lawrence AJ, Li QX, Ng AQ, Jones NC, Farrugia JJ, Abdella E, Vassalli JD, Madani R, Medcalf RL,. (2011) Compartment- and context-specific changes in tissue-type plasminogen activator (tPA) activity following brain injury and pharmacological stimulation. Lab Invest 91: 1079-1091.
30. Skrzypiec AE, Maiya R, Chen Z, Pawlak R, Strickland S,. (2009) Plasmin-mediated degradation of laminin gamma-1 is critical for ethanol-induced neurodegeneration. Biol Psychiatry 66: 785-794.
31. So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP,. (1996) Population-based study of seizure disorders after cerebral infarction. Neurology 46: 350-355. (Pubitemid 26081312)
32. Tsirka SE,. (1997) Clinical implications of the involvement of tPA in neuronal cell death. J Mol Med 75: 341-347. (Pubitemid 27247965)
33. Tsirka SE, Gualandris A, Amaral DG, Strickland S,. (1995) Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377: 340-344.
34. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J,. (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19: 604-607.
35. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA,. (1998) Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4: 228-231. (Pubitemid 28138083)
36. Wang Y, Luo W, Reiser G,. (2008) Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions. Cell Mol Life Sci 65: 237-252. (Pubitemid 351161480)
37. Wu YP, Siao CJ, Lu W, Sung TC, Frohman MA, Milev P, Bugge TH, Degen JL, Levine JM, Margolis RU, Tsirka SE,. (2000) The tissue plasminogen activator (tPA)/plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate. J Cell Biol 148: 1295-1304.
38. Yepes M, Sandkvist M, Coleman TA, Moore E, Wu JY, Mitola D, Bugge TH, Lawrence DA,. (2002) Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent. J Clin Invest 109: 1571-1578. (Pubitemid 34663519)